Abstract Young adult beagles are given single intravenous injections of monomeric 252Cf, 249Cf, 241Am, 239Pu, 228Th, 226Ra, 228Ra or 90Sr in citrate solution to achieve reproducible deposition patterns in tissue. Injected transuranium atoms become attached to transferrin and other substances in blood plasma. The skeleton and liver are the primary sites of deposition, although high local concentrations of californium, berkelium and americium also occur in the thyroid and kidney, and radium also concentrates in the eye. The initial skeletal deposition of monomeric transuranium elements is on bone surfaces. The mean local dose-rate to the soft-tissue layer 0–10 mi from the mineralized bone surfaces of the beagle is about 20 times higher when 239Pu is on bone surfaces than for an equal amount of 239Pu randomly distributed throughout the bone mineral. Thus, the rate of bone-surface remodeling has a very important influence on the skeletal toxicity of the transuranium elements. The initial liver deposition of monomeric transuranium elements is rather uniform and mainly in the hepatic cells. Subsequently, much of the radioactivity shifts into the liver reticulo-endothelial cells that line the sinusoids. At long times after injection, the distribution is very non-uniform, being highest in the portal region and lowest in the regenerative nodules. All, or virtually all, of the life-shortening from medium and low doses has been due to radiation-induced cancer. Bone sarcomas have been the most frequent form of malignancy, but head sinus carcinomas, liver tumors, and eye melanomas have also been induced. On the basis of average skeletal dose, 1 rad from 239Pu is the equivalent of 5–10 rads from 226Ra in the induction of bone sarcomas. This is because in the skeleton a considerable fraction of the 239Pu disintegrations occur on bone surfaces near cells, whereas most of the skeletal disintegrations from 226Ra take place within bone mineral. Plutonium will continue to be our chief interest, not only at low doses, but perhaps at different ages and in different chemical forms. We will continue to study other radionuclides of practical and fundamental importance. Ours is the first experiment in which tumor induction by fission fragments (252Cf) is being determined.
Read full abstract